Clinical Trial Update: A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 study of ASP8597 in adult kidney transplant patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ASP8597

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 2, Phase 3 | Status: TERMINATED